phosphatidylcholines has been researched along with Leukemia P388 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nitta, T; Saito-Taki, T; Suzuki, T | 1 |
| Bally, MB; Choi, L; Cullis, PR; de Jong, G; Longman, SA | 1 |
| Cordes, HP; Pajeva, IK; Seydel, JK; Wiese, M | 1 |
| Krishna, R; Mayer, LD | 1 |
| Ramu, A; Ramu, N; Rosario, LM | 1 |
| Fernandez-Botran, R; Suzuki, T | 1 |
| Fiallo, MM; Garnier-Suillerot, A | 1 |
7 other study(ies) available for phosphatidylcholines and Leukemia P388
| Article | Year |
|---|---|
Phospholipase A2 activity of Fc gamma 2b receptors of thioglycollate-elicited murine peritoneal macrophages.
Topics: Androgen-Binding Protein; Animals; Carrier Proteins; Immunoglobulin G; Kinetics; Leukemia P388; Macrophages; Mice; Phosphatidylcholines; Phosphatidylethanolamine Binding Protein; Phospholipases; Phospholipases A; Phospholipases A2; Phospholipid Transfer Proteins; Receptors, Fc; Receptors, IgG; Receptors, Immunologic; Rosette Formation; Thioglycolates | 1984 |
A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivo.
Topics: Animals; Bacterial Proteins; Doxorubicin; Drug Carriers; Female; Flow Cytometry; Leukemia P388; Liposomes; Metabolic Clearance Rate; Mice; Mice, Inbred Strains; Microscopy, Fluorescence; Peritoneal Lavage; Phosphatidylcholines; Streptavidin | 1995 |
Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Breast Neoplasms; Calorimetry, Differential Scanning; Dopamine Antagonists; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flupenthixol; Heterocyclic Compounds; Humans; Leukemia P388; Magnetic Resonance Spectroscopy; Membranes, Artificial; Mice; Phosphatidylcholines; Phosphatidylserines; Verapamil | 1996 |
Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cholesterol; Cyclosporins; Doxorubicin; Drug Carriers; Drug Resistance, Multiple; Female; Leukemia P388; Liposomes; Metabolic Clearance Rate; Mice; Phosphatidylcholines; Tissue Distribution | 1997 |
Circumvention of multidrug-resistance in P388 cells is associated with a rise in the cellular content of phosphatidylcholine.
Topics: Animals; Cell Membrane; Cell Membrane Permeability; Choline; Digitonin; Dipyridamole; Drug Resistance; Fura-2; Ionomycin; Leukemia P388; Lipids; Phosphatidylcholines; Potassium Chloride; Tamoxifen; Tumor Cells, Cultured; Valinomycin; Verapamil | 1991 |
Biochemical properties of phosphatidylcholine-binding proteins that share common antigenic determinants with Fc gamma 2b receptor.
Topics: Amino Acids; Animals; Antibodies, Monoclonal; Chromatography, Affinity; Detergents; Epitopes; Immunoglobulin G; Isoelectric Focusing; Leukemia P388; Mice; Octoxynol; Phosphatidylcholines; Phospholipids; Polyethylene Glycols; Receptors, Fc; Receptors, IgG; Tritium | 1985 |
Metal anthracycline complexes as a new class of anthracycline derivatives. Pd(II)-adriamycin and Pd(II)-daunorubicin complexes: physicochemical characteristics and antitumor activity.
Topics: Animals; Cardiolipins; Cell Division; Circular Dichroism; Daunorubicin; Doxorubicin; Hydrogen-Ion Concentration; Kinetics; Leukemia P388; Leukemia, Experimental; Liposomes; Male; Mice; Mice, Inbred Strains; NADH Dehydrogenase; Palladium; Phosphatidylcholines; Spectrometry, Fluorescence; Spectrophotometry; Structure-Activity Relationship | 1986 |